Conference Brief: Asembia’s AXS25 Summit: A Special Report on Specialty Pharmacy

A panel discussed the California Blues plan’s multipronged approach to pharmacy benefit management.

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium on leveraging artificial intelligence, technology and cross-functional expertise to create more personalized, efficient patient support services.

Integrated delivery networks may be crucial to meeting the challenges posed by the complexities of specialty pharmacy.

Payers may be tempted by lower prices and no rebates, but two-thirds of the respondents said their plan has experienced an increase in the amount of rebates they have received.

For payers, claims for rare disease treatments used to be uncommon. Not now with an increasing number of new, high-priced drugs for rare diseases.